Browsed by
Category: CRISPR

Science policy weekly roundup: August 16, 2019 ?>

Science policy weekly roundup: August 16, 2019

NCI to require papers funded by Cancer Moonshot be available immediately to the public In a departure from recent federal policies to allow its grantees to publish articles behind paywalls for up to one year, the National Cancer Institute is requiring that papers funded by the Cancer Moonshot program be immediately available to the public. Depending on the policy’s success, the NCI may expand this open-access requirement to its other programs. Read more here.   NIH details progress on its precision…

Read More Read More

Science policy weekly roundup: August 9, 2019 ?>

Science policy weekly roundup: August 9, 2019

Trump signs bipartisan budget deal into law The two-year budget deal, signed into law by President Donald Trump on Aug. 2, provides lawmakers with top-line budget numbers for fiscal years 2020 and 2021. It also removes federal budget caps put in place by the 2011 Budget Control Act and allows the government to borrow more money to pay its debts. The U.S. Congress must still pass the 12 appropriations bills needed to fund the federal government. The U.S. House has…

Read More Read More

Science policy weekly roundup: March 15, 2019 ?>

Science policy weekly roundup: March 15, 2019

White House 2020 budget proposes deep cuts to science President Donald Trump released his budget proposal for fiscal year 2020 on Monday. The proposal cuts the budgets of the National Institutes of Health, National Science Foundation, and Department of Energy Office of Science by at least 12 percent. However, the U.S. Congress has rejected Trump’s last two budget proposals and awarded billions to federal science agencies. Read more here. NCI Director Ned Sharpless named acting FDA commissioner National Cancer Institute…

Read More Read More

Science policy weekly roundup: July 20, 2018 ?>

Science policy weekly roundup: July 20, 2018

Episode 11 of “Pipettes and Politics” is available In the latest episode of the ASBMB science policy podcast, public affairs staff members provide updates on the fiscal year 2019 Labor Health and Human Services appropriations. Staff members also discuss the society’s August is for Advocacy annual campaign and recap the society’s response to the National Institute of General Medical Sciences’ request for input on how to increase faculty diversity. Mary Woolley, president and chief executive officer for Research!America, joins the…

Read More Read More

The ASBMB co-hosts Capitol Hill briefing on role of NSF in breakthrough genetic discoveries ?>

The ASBMB co-hosts Capitol Hill briefing on role of NSF in breakthrough genetic discoveries

The American Society for Biochemistry and Molecular Biology, in partnership with the American Chemical Society, hosted a briefing for congressional staffers on Thursday about the role of National Science Foundation funding in the development of innovative genetic tools. The briefing highlighted the discovery of CRISPR, which was enabled by a small NSF grant for the study of bacterial defenses against viruses. The revolutionary gene-editing tool, over the long term, is likely to have substantial societal impacts, with applications in the…

Read More Read More

UPDATE: Broad Institute claims victory in CRISPR intellectual property case ?>

UPDATE: Broad Institute claims victory in CRISPR intellectual property case

Previously we reported on the ongoing battle for intellectual property patent ownership of the CRISPR gene-editing technology between the University of California at Berkeley and the Broad Institute of the Massachusetts Institute of Technology and Harvard University. In this case, UC Berkeley challenged multiple patents filed by the Broad Institute on the grounds that they overlapped or interfered with existing patents held by UC Berkeley. On Feb 15, the U.S. Patent and Trademark Office court ruled in favor of the…

Read More Read More

Who owns the CRISPR gene editing method? ?>

Who owns the CRISPR gene editing method?

On December 6, the U.S. Patent and Trademark Office began hearing arguments from The University of California, Berkeley and the Broad Institute, a joint collaborative effort between the Massachusetts Institute of Technology and Harvard University, regarding the intellectual property ownership of the gene editing method known as the CRISPR/Cas system. UC Berkeley was the first to file a patent for this method, while the Broad Institute has previously won multiple awards regarding its research on this system and has filed…

Read More Read More